Biomarkers for molecular-based diagnostic product

Using Machine Learning to identify key biomarkers

Biomarker discovery is essential for molecular diagnostics. Machine Learning (ML) improves biomarker identification and validation for diagnostic applications.

Challenge

The client needed a robust ML framework to analyze omics data from 700–800 patient samples, with 7,000–8,000 gene expression features and 2,000 SNP features.

Approach

  • Performed multi-stage, nested cross-validation.
  • Used feature engineering based on interaction networks.
  • Evaluated and delivered the top three ML models for validation.

Results

  • Established a panel of biomarkers validated for blood-based assays.
  • Delivered ML models with superior predictive performance.

Artificial Intelligence-based biomarker discovery is boosting advances in diagnostics, providing accurate and reliable disease detection.

Want to achieve similar efficiency gains? Let's discuss how we can optimize your clinical project.

You might be also interested in:

Can AI Stop the Cost Spiral in Drug Discovery? Summary of Our Expert Talk at BioTech X 2025
Your monthly AI in biotech digest – October
Abstract visualization of AI-driven analysis of patient data, representing precision medicine and responder identification.
Precision Trials: Using AI to Identify Responders
Poster: Safer pHLA-Targeted Immunotherapies Through AI and Computational Immunology

Contact

Ready to transform drug discovery?

Discover how one of the top AI CROs in the world, can be your trusted partner in revolutionizing drug discovery through AI.

Contact us today to learn more about our tailored solutions for empowering your drug development journey.

Send us a message and we will contact you back within 48 hours.

Newsletter

Become an insider

Be the first to know about Ardigen’s latest news and get access to our publications, webinars and more!